Page last updated: 2024-11-04

scriptaid and Cancer of Ovary

scriptaid has been researched along with Cancer of Ovary in 2 studies

scriptide: provokes translocation of GLUT4 to increase glucose uptake; structure in first source

Research Excerpts

ExcerptRelevanceReference
"Incubation of ovarian cancer cells with scriptaid and bortezomib (or doxorubicin) led to synergistic antitumor effects."1.48Synergistic antitumor effects of histone deacetylase inhibitor scriptaid and bortezomib against ovarian cancer cells. ( Janyst, K; Janyst, M; Lasek, W; Siernicka, M, 2018)
"Endometrial and ovarian cancer cells were treated with various concentrations of Scriptaid, and its effect on cell growth, cell cycle, apoptosis, and related measurements was investigated."1.33A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells. ( Narahara, H; Nasu, K; Nishida, M; Takai, N; Ueda, T, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Janyst, K1
Janyst, M1
Siernicka, M1
Lasek, W1
Takai, N1
Ueda, T1
Nishida, M1
Nasu, K1
Narahara, H1

Other Studies

2 other studies available for scriptaid and Cancer of Ovary

ArticleYear
Synergistic antitumor effects of histone deacetylase inhibitor scriptaid and bortezomib against ovarian cancer cells.
    Oncology reports, 2018, Volume: 39, Issue:4

    Topics: Apoptosis; Bortezomib; Caspases; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Female; Gene

2018
A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.
    International journal of molecular medicine, 2006, Volume: 17, Issue:2

    Topics: Annexin A5; Apoptosis; Cell Cycle; Cell Line, Tumor; Endometrial Neoplasms; Enzyme Inhibitors; Epith

2006